Josef M. Miller
Corporate Officer/Principal bei University of Michigan
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
David E. Cole | M | - |
University of Michigan
| - |
Peter Sjöstrand | M | 78 |
Karolinska Institutet
| - |
Hans Lennart Rudolf Wigzell | M | 86 |
Karolinska Institutet
| 29 Jahre |
James R. Baker | M | - |
University of Michigan
| - |
Anna Martling | M | 55 |
Karolinska Institutet
| - |
Stephen R. Forrest | M | 73 |
University of Michigan
| 18 Jahre |
Craig Parker | M | 63 |
University of Michigan
| 19 Jahre |
Klas Kärre | M | 70 |
Karolinska Institutet
| - |
Thomas Perlmann | M | - |
Karolinska Institutet
| - |
Michael Johnson | M | 68 |
University of Michigan
| - |
James Johnson Duderstadt | M | 80 |
University of Michigan
| 36 Jahre |
Robert P. Kelch | M | - |
University of Michigan
| - |
Arnold J. Sameroff | M | - |
University of Michigan
| - |
Samuel J. Meisels | M | - |
University of Michigan
| - |
Victor M. Elner | M | - |
University of Michigan
| - |
Paul N. Courant | M | - |
University of Michigan
| - |
Anne C. Petersen | M | - |
University of Michigan
| 14 Jahre |
James Timberlake | M | - |
University of Michigan
| - |
David K. Cohen | M | - |
University of Michigan
| - |
Angela F. Caveney | M | - |
University of Michigan
| - |
Alan H. Foster | M | 87 |
University of Michigan
| - |
Daryl R. Kipke | M | - |
University of Michigan
| - |
David R. Ginsburg | M | 71 |
University of Michigan
| - |
Kenneth Nisbet | M | - |
University of Michigan
| - |
Jun Ni | M | 61 |
University of Michigan
| 37 Jahre |
Bruce R. Maxim | M | 70 |
University of Michigan
| 33 Jahre |
Jess Gilbert Thoene | M | 81 |
University of Michigan
| - |
Ralph J. Gerson | M | 73 |
University of Michigan
| - |
Arul Chinnaiyan | M | - |
University of Michigan
| - |
Daniel D. Rhodes | M | - |
University of Michigan
| - |
Brian Hackett | M | - |
University of Michigan
| - |
Sandra G. Yee | F | - |
University of Michigan
| - |
Margaret Marchak | F | - |
University of Michigan
| - |
Feng Li | M | 48 |
University of Michigan
| - |
Kathryn Dominguez | F | - |
University of Michigan
| - |
Michael Holinstat | M | 52 |
University of Michigan
| - |
Sarah Hubbard | F | - |
University of Michigan
| - |
Jim Mettlach | M | - |
University of Michigan
| - |
Cheryl Soper | F | - |
University of Michigan
| - |
Emily Falk | F | - |
University of Michigan
| - |
Vallerie Mclaughlin | M | 60 |
University of Michigan
| 21 Jahre |
David Bosch | M | - |
University of Michigan
| - |
Frederick K. Askari | M | - |
University of Michigan
| - |
Andrew Ross | M | 57 |
University of Michigan
| - |
Hwa-Jin Kim | M | 64 |
University of Michigan
| - |
Barbara L. McQuade | F | 59 |
University of Michigan
| - |
Alec Gallimore | M | 60 |
University of Michigan
| 32 Jahre |
Aaron Hodari | M | 37 |
University of Michigan
| - |
Marschall Runge | M | 69 |
University of Michigan
| 9 Jahre |
Satish Tadikonda | M | - |
University of Michigan
| 4 Jahre |
Arik Ruchim | M | 43 |
University of Michigan
| - |
Alexander Green | M | 60 |
University of Michigan
| - |
Nicholas A. Kotov | M | - |
University of Michigan
| - |
John Schwarz | M | - |
University of Michigan
| - |
Sanjay Shah | M | 55 |
University of Michigan
| - |
Roderick D. Davies | M | 76 |
University of Michigan
| - |
John W. Barfield | M | - |
University of Michigan
| - |
Lee Hess | M | - |
University of Michigan
| - |
Farnam Jahanian | M | - |
University of Michigan
| - |
Mike Beauregard | M | - |
University of Michigan
| 19 Jahre |
Allen S. Lichter | M | 77 |
University of Michigan
| 26 Jahre |
Bertram Pitt | M | 92 |
University of Michigan
| 47 Jahre |
Samuel Valenti | M | 78 |
University of Michigan
| - |
James W. Richards | M | - |
University of Michigan
| - |
Sanford Robertson | M | 92 |
University of Michigan
| - |
Ellen Offner | F | - |
University of Michigan
| - |
Frank Newman | M | 75 |
University of Michigan
| - |
Lennard A. Fisk | M | 80 |
University of Michigan
| 31 Jahre |
Jeoffrey K. Stross | M | 82 |
University of Michigan
| 37 Jahre |
Todd W. Herrick | M | 81 |
University of Michigan
| - |
Harry Pearce | M | 81 |
University of Michigan
| - |
Adesoji Adelaja | M | 70 |
University of Michigan
| - |
Mary Petrovich | F | 61 |
University of Michigan
| - |
Thomas G. Stephens | M | 75 |
University of Michigan
| - |
Robert Burch | M | - |
University of Michigan
| - |
David J. Brophy | M | 87 |
University of Michigan
| - |
Renard Charity | M | - |
University of Michigan
| - |
Scott J. Hollister | M | - |
University of Michigan
| - |
Eric W. Olle | M | - |
University of Michigan
| - |
Mike Montenaro | M | - |
University of Michigan
| - |
Rainer Schmitt | M | - |
University of Michigan
| - |
Corey Horowitz | M | 69 |
University of Michigan
| - |
Thomas D. Posey | M | - |
University of Michigan
| - |
Peter Schweitzer | M | - |
University of Michigan
| - |
Robert P. Aronson | M | - |
University of Michigan
| - |
Stephen E. Feinberg | M | - |
University of Michigan
| - |
Paul B. Hays | M | - |
University of Michigan
| 57 Jahre |
James S. Slubowski | M | - |
University of Michigan
| - |
Glen Thomas Daigger | M | - |
University of Michigan
| - |
Kristyn Rene Aalto | F | - |
University of Michigan
| - |
Thomas N. Gladwin | M | 74 |
University of Michigan
| 26 Jahre |
Thomas F. Haddock | M | - |
University of Michigan
| - |
H. David Humes | M | - |
University of Michigan
| - |
Ora Hirsch Pescovitz | M | 67 |
University of Michigan
| - |
Victor J. Strecher | M | - |
University of Michigan
| - |
Hal Davis | M | - |
University of Michigan
| - |
Bill Muir | M | - |
University of Michigan
| - |
Brandon Soloski | M | - |
University of Michigan
| 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
David Clark Bennett | M | - |
OtoMedicine, Inc.
OtoMedicine, Inc. Pharmaceuticals: OtherHealth Technology OtoMedicine, Inc. is a new biopharmaceutical company, founded in 2006, to commercialize more than two decades of scientific research and technology developed in the laboratories of Dr. Josef Miller at the University of Michigan's Kresge Hearing Research Institute. OtoMedicine's mission is to become the leading provider of medicines to prevent, treat, and cure hearing loss. Its initial focus is to amplify, in a compelling manner, the evidence it has already gathered to demonstrate that a proprietary combination of compounds can dramatically reduce noise-induced hearing loss (NIHL), one of the most prevalent disabling conditions in the industrialized world and for which there is no FDA-approved means of treatment. Called AuraquellTM, this specific combination of micronutrients has already been shown to provide significant synergistic protection against noise-induced injury in pre-clinical studies with animal subjects. In other words, the protection resulting from administration of the combination was greater than that following any of the ingredients individually. Based on the dramatic protection observed in pre-clinical studies, this formulation is expected to be a highly effective therapy for prevention of NIHL in humans. | 9 Jahre |
Peter A. Boxer | M | - |
OtoMedicine, Inc.
OtoMedicine, Inc. Pharmaceuticals: OtherHealth Technology OtoMedicine, Inc. is a new biopharmaceutical company, founded in 2006, to commercialize more than two decades of scientific research and technology developed in the laboratories of Dr. Josef Miller at the University of Michigan's Kresge Hearing Research Institute. OtoMedicine's mission is to become the leading provider of medicines to prevent, treat, and cure hearing loss. Its initial focus is to amplify, in a compelling manner, the evidence it has already gathered to demonstrate that a proprietary combination of compounds can dramatically reduce noise-induced hearing loss (NIHL), one of the most prevalent disabling conditions in the industrialized world and for which there is no FDA-approved means of treatment. Called AuraquellTM, this specific combination of micronutrients has already been shown to provide significant synergistic protection against noise-induced injury in pre-clinical studies with animal subjects. In other words, the protection resulting from administration of the combination was greater than that following any of the ingredients individually. Based on the dramatic protection observed in pre-clinical studies, this formulation is expected to be a highly effective therapy for prevention of NIHL in humans. | 7 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 95 | 95,00% |
Schweden | 5 | 5,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Josef M. Miller
- Persönliches Netzwerk